Y-mAbs Therapeutics, Inc. Quarterly Operating Lease, Liability, Noncurrent in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Y-mAbs Therapeutics, Inc. quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q1 2019 to Q2 2024.
  • Y-mAbs Therapeutics, Inc. Operating Lease, Liability, Noncurrent for the quarter ending June 30, 2024 was $432K, a 3.85% increase year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $432K +$16K +3.85% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $293K -$336K -53.4% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $517K -$382K -42.5% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $725K -$294K -28.9% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $416K -$886K -68% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $629K -$969K -60.6% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $899K -$952K -51.4% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $1.02M +$365K +55.8% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $1.3M +$314K +31.8% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $1.6M +$83K +5.48% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $1.85M -$162K -8.05% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $654K -$1.86M -74% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $988K -$411K -29.4% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $1.52M -$28K -1.82% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $2.01M +$299K +17.4% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $2.52M +$696K +38.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.4M -$581K -29.3% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $1.54M -$590K -27.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $1.71M Dec 31, 2019 10-K 2021-03-01
Q3 2019 $1.82M Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $1.98M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $2.13M Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.